Today, 7,500 Shares of Stock are sold by Medidata Solutions Inc. (MDSO) President Vries Glen Michael De

Today, 7,500 Shares of Stock are sold by Medidata Solutions Inc. (MDSO) President Vries Glen Michael De

Medidata Solutions Inc. (NASDAQ:MDSO) President Vries Glen Michael De sold 7,500 shares of the firm’s stock in a transaction that occurred on Tuesday, October 11th. The shares were sold at an average price of $54.72, for a total transaction of $410,400.00. Following the completion of the sale, the president now directly owns 942,653 shares in the company, valued at $51,581,972.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Vries Glen Michael De also recently made the following trade(s): On Monday, September 12th, Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock. The stock was sold at an average price of $53.70, for a total transaction of $402,750.00. On Tuesday, August 9th, Vries Glen Michael De sold 7,500 shares of Medidata Solutions stock. The stock was sold at an average price of $54.39, for a total transaction of $407,925.00.

Shares of Medidata Solutions Inc. (NASDAQ:MDSO) opened at 49.70 on Monday. The company has a market cap of $2.76 billion, a PE ratio of 127.76 and a beta of 1.29. The company has a 50-day moving average of $54.90 and a 200 day moving average of $48.50. Medidata Solutions Inc. has a 12-month low of $30.22 and a 12-month high of $57.21.

Medidata Solutions (NASDAQ:MDSO) last posted its earnings results on Wednesday, July 20th. The company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. The firm earned $114.60 million during the quarter, compared to the consensus estimate of $112.39 million. Medidata Solutions had a return on equity of 10.32% and a net margin of 5.29%. The company’s quarterly revenue was up 16.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.22 EPS. On average, equities research analysts expect that Medidata Solutions Inc. will post $1.01 EPS for the current year.

Several research analysts have commented on the stock. Wells Fargo & Co. downgraded shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 21st. Deutsche Bank AG lifted their price target on shares of Medidata Solutions from $56.00 to $58.00 and gave the stock a “buy” rating in a research note on Tuesday, September 13th. KeyCorp reissued a “buy” rating on shares of Medidata Solutions in a research note on Thursday, July 7th. Zacks Investment Research downgraded shares of Medidata Solutions from a “buy” rating to a “hold” rating in a research note on Wednesday, July 13th. Finally, Needham & Company LLC assumed coverage on shares of Medidata Solutions in a research note on Monday, July 11th. They set a “buy” rating and a $55.00 price target on the stock. One research analyst has rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the stock. Medidata Solutions currently has an average rating of “Buy” and an average target price of $54.09.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. FMR LLC increased its position in Medidata Solutions by 15.2% in the second quarter. FMR LLC now owns 6,908,046 shares of the company’s stock worth $323,780,000 after buying an additional 913,489 shares in the last quarter. Vanguard Group Inc. increased its position in Medidata Solutions by 4.7% in the second quarter. Vanguard Group Inc. now owns 4,435,841 shares of the company’s stock worth $207,909,000 after buying an additional 200,142 shares in the last quarter. BlackRock Fund Advisors increased its position in Medidata Solutions by 3.1% in the second quarter. BlackRock Fund Advisors now owns 3,607,217 shares of the company’s stock worth $169,070,000 after buying an additional 109,795 shares in the last quarter. Champlain Investment Partners LLC increased its position in Medidata Solutions by 8.4% in the second quarter. Champlain Investment Partners LLC now owns 1,530,610 shares of the company’s stock worth $71,740,000 after buying an additional 118,150 shares in the last quarter. Finally, BlackRock Institutional Trust Company N.A. increased its position in Medidata Solutions by 2.0% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,387,163 shares of the company’s stock worth $65,016,000 after buying an additional 27,799 shares in the last quarter.

About Medidata Solutions

Related posts

Leave a Comment